U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX7513722: GSM4254169: scRNA-seq of HUVEC in DM Control [103838-001-002_S6]; Homo sapiens; RNA-Seq
1 ILLUMINA (Illumina NovaSeq 6000) run: 199.2M spots, 37.2G bases, 14.8Gb downloads

Submitted by: NCBI (GEO)
Study: The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition [HTS]
show Abstracthide Abstract
Endothelial cells play an important role in maintenance of the vascular system and the repair after injury. Under pro-inflammatory conditions, endothelial cells can acquire a mesenchymal phenotype by a process named endothelial-to-mesenchymal transition (EndMT), which affects the functional properties of endothelial cells. Here, we investigated the epigenetic control of EndMT. We show that the histone demethylase JMJD2B is induced by EndMT promoting pro-inflammatory and hypoxic conditions. Silencing of JMJD2B reduced TGF-ß2-induced expression of mesenchymal genes and prevented the alterations in endothelial morphology and impaired endothelial barrier function. Endothelial-specific deletion of JMJD2B in vivo confirmed a reduction of EndMT after myocardial infarction. EndMT did not affect global H3K9me3 levels but induced a site-specific reduction of repressive H3K9me3 marks at promoters of mesenchymal genes, such as Calponin (CNN1), and genes involved in TGF-ß signaling, such as AKT Serine/Threonine Kinase 3 (AKT3) and sulfatase 1 (SULF1). Silencing of JMJD2B prevented the EndMT-induced reduction of H3K9me3 marks at these promotors and further repressed these EndMT-related genes. Our study reveals that endothelial identity and function is critically controlled by the histone demethylase JMJD2B, which is induced by EndMT-promoting pro-inflammatory and hypoxic conditions and support the acquirement of a mesenchymal phenotype. Overall design: 1.) CHIP-SEQ of H3K9me3 in HUVECS in full-(FM) and differentiation medium (DM) 2.) Whole Transcriptome RNA-SEQ of HUVECS in full-(FM) and differentiation medium (DM) 3.) Single Cell RNA-SEQ of whole heart of Jmjd2b flox Cdh5-iCre and wildtype mice 3 days after AMI 4.) Single Cell RNA-SEQ of HUVECS full-(FM) and differentiation medium (DM) 5.) Single Cell RNA-SEQ of HUVECS in full medium (FM) under scrambled knockdown and differentiation medium (DM) under scrambled knockdown and JMJD2B knockdown
Sample: scRNA-seq of HUVEC in DM Control [103838-001-002_S6]
SAMN13746745 • SRS5953446 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: Illumina NovaSeq 6000
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: Total RNA was isolated using Qiazol Lysis Reagent (#79306; Qiagen) and miRNeasy-kit (#217004; Qiagen) with additional DNase I (#79254; Qiagen) digestion according to the manufacturer's protocol. 1 μg of RNA from each sample was reverse-transcribed using random hexamer primed single-strand cDNA (10 min at 25 °C, 15 min at 42 °C, 5 min at 99 °C) by MMLV Reverse Transcriptase (#N8080018; Life technologies) as previously described. (Boeckel et al., 2011). For qPCR, cDNA was amplified using Fast SYBR Green Mastermix (#4385612 Life Technologies) on a ViiA7- Realtime qPCR System (Life Technologies). Expression level of mRNAs were normalized to RPLP0 which served as a housekeeping gene using the 2‑ΔCt method. 900ng of total RNA was used as input for whole transcriptome RNA-seq library preparation (TruSeq® Stranded Total RNA, Illumina) following low throughput protocol. Sequencing was performed on Illumina Nextseq 500 (Illumina) using V2 chemistry and 75bp single-end setup.
Experiment attributes:
GEO Accession: GSM4254169
Links:
Runs: 1 run, 199.2M spots, 37.2G bases, 14.8Gb
Run# of Spots# of BasesSizePublished
SRR10842915199,172,00537.2G14.8Gb2020-01-08

ID:
9810102

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...